Overview Technical Risk & rank Quality Results Accounts Filings Options Guidance & governance
Filings
87 filings of NAVINFLUOR since November 2024; the newest 40 below.
presentation 55, board outcome 12, transcript 8, dividend 5, credit rating 4, results 2
| Filed | Type | Subject | |
|---|---|---|---|
| 13 Nov 2026 | presentation | Navin Fluorine International Limited has informed the Exchange about Schedule of meet and PresentationAI summaryNavin Fluorine International Limited filed an intimation of analyst/institutional investor meets under Regulation 30 of the SEBI LODR Regulations. Officials will interact with analysts and investors on November 18, 2026 at the JM Financial Annual India Conference (India Xchange 2026), via physical one-on-one and group meetings. A presentation to be used at the meetings is enclosed; discussions will be based on publicly available information. The company notes changes may occur due to exigencies on the part of the host or company. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 11 Nov 2026 | presentation Acquisition, Capex, Results | Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the officials of Navin Fluorine International Limited ('the Company') will be interacting with Analysts AI summaryNavin Fluorine International intimated analyst/investor meets on November 16 and 17, 2026 at the 360 One-Trinity Asia Conference (physical, one-on-one and group meetings), and filed its investor presentation dated October 30, 2026. H1 FY27 consolidated sales were Rs. 2,235.8 Cr (+51% YoY), operating EBITDA Rs. 764.5 Cr (+69% YoY), operating EBITDA margin 34.2% (+367 bps YoY), and operating PBT Rs. 619.2 Cr (+93% YoY). Q2 FY27 consolidated sales were Rs. 1,190.7 Cr (+57% YoY, +14% QoQ), operating EBITDA Rs. 407.5 Cr (+66% YoY, +14% QoQ), and operating PBT Rs. 336.0 Cr (+87% YoY, +19% QoQ). Management said HFC realisations rose QoQ with a firm pricing environment and that HFO supply contract with Solstice Advanced Materials US was extended by 4 years, with additional revenue potential of about $180 million and total contract value of about $590 million over 11 years. Management said additional HFC capacity equivalent to up to 15,000 MTPA of R32 is on track to be commissioned shortly, and the Dahej MPP de-bottlenecking was commissioned in September 2026; the Chemours project is targeted for completion by end of Q3 FY27. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 06 Nov 2026 | transcript Capex, Dividend / buy-back, Guidance, Management change, Results | Navin Fluorine International Limited has informed the Exchange about TranscriptAI summaryNavin Fluorine filed the transcript of its Q2 and H1 FY27 earnings call held on October 30, 2026. Management said Q2 consolidated operating revenue rose 57% year-on-year to INR1,191 crores, operating EBITDA rose 66% to INR407 crores (margin 34.2%), and PAT rose 81% to INR269 crores. For H1 FY27, operating revenue rose 51% to INR2,236 crores, operating EBITDA rose 69% to INR765 crores, and PAT rose 93% to INR513 crores, with EPS of INR100. Management said the Board declared an interim dividend of INR8 per equity share (face value INR2). Management said the Solstice HFO supply contract was extended by 4 years to December 2032, with additional revenue potential of about USD180 million. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Oct 2026 | presentation Capex, Guidance, Results | Navin Fluorine International Limited has informed the Exchange about Investor PresentationAI summaryNavin Fluorine International filed its investor presentation for Q2 and H1 of FY 2026-27 (quarter and half year ended September 30, 2026). Q2 FY27 consolidated sales were Rs. 1,190.7 Cr, up 57% YoY and 14% QoQ; operating EBITDA up 66% YoY; operating PBT up 87% YoY. H1 FY27 consolidated sales were Rs. 2,235.8 Cr, up 51% YoY; operating EBITDA up 69% YoY; operating PBT up 93% YoY; operating EBITDA margin 34.2%, up 367 bps YoY. Management said HFC pricing remains firm with QoQ realisation increases, and the HFC capacity capex of up to 15,000 MTPA of R32 is on track to be commissioned shortly. Management said an HFO supply contract with Solstice Advanced Materials US was extended by 4 years, adding about $180 million of revenue potential, for a total contract value of about $590 million over 11 years. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Oct 2026 | dividend Dividend / buy-back, Results | Navin Fluorine International Limited has informed the Exchange that Board of Directors at its meeting held on October 30, 2026, declared Interim Dividend of Rs. 8 per equity share.AI summaryBoard of Navin Fluorine International Limited approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, with limited review reports from Price Waterhouse Chartered Accountants LLP. Consolidated revenue from operations for the quarter ended September 30, 2026 was ₹1,190.74 crore, against ₹758.42 crore a year earlier; consolidated profit after tax was ₹269.24 crore, against ₹148.37 crore. Board declared an interim dividend of ₹8 per equity share of face value ₹2 (400% of face value) for FY 2026-27, with record date November 5, 2026 and payment on or after November 26, 2026. Board approved sending a final reminder for final call money on 8,060 partly paid equity shares (₹1 per share paid), with interest, failing which the shares will be forfeited. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Oct 2026 | board outcome Dividend / buy-back, Legal, Results | Navin Fluorine International Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.AI summaryNavin Fluorine International Limited's board meeting held on October 30, 2026 approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. Consolidated revenue from operations for the quarter ended September 30, 2026 was ₹1,190.74 crores, against ₹758.42 crores a year earlier; consolidated profit after tax was ₹269.24 crores, against ₹148.37 crores. Consolidated revenue from operations for the half year ended September 30, 2026 was ₹2,235.82 crores; consolidated profit after tax was ₹512.55 crores. The board declared an interim dividend of ₹8 per equity share (face value ₹2) for FY 2026-27, with record date November 5, 2026 and payment on or after November 26, 2026. The board approved sending a final reminder for final call money on 8,060 partly paid equity shares, failing which the shares will be forfeited. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Sep 2026 | presentation Capex, Legal, Results | Navin Fluorine International Limited has informed the Exchange about Schedule of meet and PresentationAI summaryIntimation of analyst/investor meets: officials of Navin Fluorine International Limited will interact with analysts and investors on October 12, 2026 at the Goldman Sachs India – Hidden Gems conference (virtual, one-on-one and group meetings). Presentation enclosed; discussions will be based on publicly available information and changes may occur due to exigencies. Q1 FY27 consolidated sales Rs. 1,045.1 Cr, up 44% YoY and 11% QoQ; operating EBITDA up 73% YoY; operating PBT up 101% YoY. HPP revenue Rs. 540 Cr (Q1 FY27 vs Rs. 407 Cr in Q1 FY26, +33%); Specialty Chemicals Rs. 325 Cr (vs Rs. 219 Cr, +48%); CDMO Rs. 180 Cr (vs Rs. 99 Cr, +82%). Management said Phase II cGMP4 CDMO capex of Rs. 125 Cr is expected to operationalize by Q4 FY27, and HFC capacity capex equivalent to up to 15,000 MTPA of R32 is on track for commissioning in Q3 FY27. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 16 Sep 2026 | credit rating Rating | Navin Fluorine International Limited has informed the Exchange about Credit Rating- NewAI summaryNavin Fluorine International Limited intimated, under Regulation 30 of SEBI Listing Regulations, a revision in credit rating. Niche99 ESG Ratings reviewed the company's ESG rating and assigned a rating of '64.54 Performer', as per an email received by the company on September 15, 2026. The company states it has not engaged Niche99 for the ESG rating; the report was prepared independently from public domain data. Details are available at www.niche99.com. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 07 Sep 2026 | presentation Capex, Guidance, Management change, Results | Navin Fluorine International Limited has informed the Exchange about Schedule of meet and PresentationAI summaryNavin Fluorine International intimated that its officials will meet analysts and investors on September 21, 2026 at the Anand Rathi G-200 Summit 2026 (physical one-on-one and group meetings), and enclosed the presentation. Q1 FY27 consolidated sales were Rs. 1,045.1 Cr, up 44% YoY and 11% QoQ; operating EBITDA was up 73% YoY and operating PBT up 101% YoY. Operating EBITDA margin was up 566 bps YoY and down 8 bps QoQ. HPP revenue was Rs. 540 Cr (Q1 FY26: Rs. 407 Cr, +33%); Specialty Chemicals revenue was Rs. 325 Cr (Rs. 219 Cr, +48%); CDMO revenue was Rs. 180 Cr (Rs. 99 Cr, +82%). Management said HPP pricing for HFC remains constructive, the R32 capacity addition is on track for Q3 FY27, the Chemours project is targeted for completion by end of Q2 FY27, and Phase II cGMP4 capex of Rs. 125 Cr is expected to operationalize by Q4 FY27. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 07 Sep 2026 | presentation Capex, Guidance, Results | Navin Fluorine International Limited has informed the Exchange about Schedule of meet and PresentationAI summaryNavin Fluorine International intimated analyst/institutional investor meetings on September 16 and 17, 2026 at the Jefferies India Forum (physical, one-on-one and group meetings), and enclosed its investor presentation. Q1 FY27 consolidated sales were Rs. 1,045.1 Cr, up 44% YoY and 11% QoQ; operating EBITDA rose 73% YoY to Rs. 938 Cr (per the presentation's chart) and operating PBT rose 101% YoY. Segment revenue in Q1 FY27: HPP Rs. 540 Cr (+33% YoY), Specialty Chemicals Rs. 325 Cr (+48% YoY), CDMO Rs. 180 Cr (+82% YoY). Management said HFC pricing remains constructive, the AHF facility began operations in Q4 FY26, and additional HFC capacity of up to 15,000 MTPA of R32 is on track for Q3 FY27 commissioning. Management said the Chemours project is targeted for completion by end of Q2 FY27, and Phase II cGMP4 CDMO capex of Rs. 125 Cr is expected to operationalise by Q4 FY27. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 18 Aug 2026 | credit rating Rating | Navin Fluorine International Limited has informed the Exchange about Credit Rating- NewAI summaryNavin Fluorine International Limited intimated under Regulation 30 of SEBI Listing Regulations that, per an email received on August 17, 2026, Crisil ESG Ratings & Analytics Limited reviewed its ESG rating. Crisil ESG Ratings assigned an ESG rating of 'Crisil ESG 62' and a Core ESG rating of 'Crisil Core ESG 66'. The company has stated it did not engage Crisil ESG Ratings & Analytics Limited for the ESG rating, and the report was prepared independently from public domain data. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 17 Aug 2026 | presentation Capex, Guidance, Results | Navin Fluorine International Limited has informed the Exchange about Schedule of meet and PresentationAI summaryNavin Fluorine International filed an intimation of an analyst/institutional investor group meeting on August 20, 2026 at 10:00 AM (IST), with the investor presentation enclosed. Q1 FY27 consolidated sales were Rs. 1,045.1 Cr, up 44% YoY and 11% QoQ; operating EBITDA was up 73% YoY and operating PBT up 101% YoY, with operating EBITDA margin up 566 bps YoY. HPP revenue rose 33% YoY to Rs. 540 Cr; Specialty Chemicals revenue rose 48% YoY to Rs. 325 Cr; CDMO revenue rose 82% YoY to Rs. 180 Cr. Management said the AHF facility commenced operations in Q4 FY26, HFC capacity equivalent to up to 15,000 MTPA of R32 is on track for Q3 FY27, and the Chemours project is targeted for completion by end of Q2 FY27. Management said Phase II cGMP4 capex of Rs. 125 Cr for CDMO was initiated and is expected to operationalise by Q4 FY27. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 13 Aug 2026 | credit rating Rating | Navin Fluorine International Limited has informed the Exchange about Credit Rating- RevisionAI summaryNavin Fluorine International Limited filed intimation under Regulation 30 of SEBI Listing Regulations on a credit rating revision by CARE Ratings Limited. Long-term bank facilities of Navin Fluorine International Limited upgraded from CARE AA; Stable to CARE AA+; Stable. Long-term bank facilities (credit enhanced) of wholly owned subsidiary Navin Fluorine Advanced Sciences Limited upgraded from CARE AA (CE); Stable to CARE AA+ (CE); Stable. Long-term bank facilities (unsupported) of Navin Fluorine Advanced Sciences Limited upgraded from CARE AA- to CARE AA. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 11 Aug 2026 | transcript Capex, Guidance, Results | Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the transcript of the Company s Earnings Call held on August 05, 2026 regarding discussion on operational and finaAI summaryNavin Fluorine filed the transcript of its Q1 FY27 earnings call held on August 05, 2026, covering the quarter ended June 30, 2026. Management reported consolidated revenue of INR1,045 crores (up 44% YoY), operating EBITDA of INR357 crores (up 73% YoY, margin 34.2%), and PAT of INR243 crores (up 108% YoY); the company also became net debt free during the quarter. Management announced a new capex of INR90 crores, funded by internal accruals, for advanced materials adoption capacity, and Phase 2 cGMP4 capex of INR125 crores in the CDMO business, expected to be operational by Q4 FY27. Management said the HFC capacity expansion (up to 15,000 metric tons of R32) remains on track for commissioning in Q3 FY27, and that the Chemours project is targeted for completion by end of Q2 FY27. Management said it has strong visibility of campaign orders for four to five molecules in the agchem space this year. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 05 Aug 2026 | presentation Capex, Guidance, Results | Navin Fluorine International Limited has informed the Exchange about Investor PresentationAI summaryNavin Fluorine International filed its investor presentation for Q1 FY27 (quarter ended June 30, 2026) on August 5, 2026. Consolidated sales were Rs. 1,045.1 Cr, up 44% YoY and 11% QoQ; operating EBITDA was up 73% YoY and 11% QoQ, with operating EBITDA margin up 566 bps YoY. Operating PBT rose 101% YoY and 13% QoQ. Segment revenue: HPP Rs. 540 Cr (up 33% YoY), Specialty Chemicals Rs. 325 Cr (up 48% YoY), CDMO Rs. 180 Cr (up 82% YoY). Management said the HFC capex for up to 15,000 MTPA of R32 is on track for Q3 FY27 commissioning, and Phase II cGMP4 capex of Rs. 125 Cr in CDMO is expected to be operational by Q4 FY27. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 05 Aug 2026 | board outcome Capex, Results | Navin Fluorine International Limited has informed the Exchange regarding Outcome of Board Meeting held on August 05, 2026.AI summaryNavin Fluorine International Limited's board approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026 at its meeting held on August 05, 2026, with limited review reports from Price Waterhouse Chartered Accountants LLP. Consolidated total revenue for the quarter ended June 30, 2026 was ₹1,080.17 crores, against ₹739.31 crores in the quarter ended June 30, 2025. Consolidated profit after tax was ₹243.31 crores for the quarter ended June 30, 2026, against ₹117.17 crores in the quarter ended June 30, 2025. Basic EPS (not annualised) was ₹47.45 for the quarter ended June 30, 2026, against ₹23.63 a year earlier. The board approved capital expenditure of ₹90 crores for establishing adoption capacities for Advanced Materials portfolio products, from lab scale to commercial scale qualification, at the Surat unit. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 05 Aug 2026 | board outcome Capex, Results | Navin Fluorine International Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.AI summaryBoard of Navin Fluorine International Limited approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with limited review reports from Price Waterhouse Chartered Accountants LLP. Consolidated revenue from operations for the quarter ended June 30, 2026 was ₹1,045.08 crores, against ₹937.71 crores in the March 31, 2026 quarter and ₹725.40 crores in the June 30, 2025 quarter. Consolidated profit after tax for the quarter ended June 30, 2026 was ₹243.31 crores, against ₹212.62 crores in the March 31, 2026 quarter and ₹117.17 crores in the June 30, 2025 quarter. The Board approved capital expenditure of ₹90 crores for adoption capacities for Advanced Materials portfolio products, moving from lab scale to commercial scale qualification, at the Surat unit. The board meeting ran from 1:30 P.M. to 4:05 P.M. (IST) on August 5, 2026. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 21 May 2026 | presentation Results | Navin Fluorine International Limited has informed the Exchange about Schedule of meet and PresentationAI summaryIntimation of analyst/institutional investor meetings: company officials to interact with analysts and investors at Jefferies Singapore (June 9-10, 2026) and Jefferies Hong Kong (June 11-12, 2026), physical one-on-one and group meetings; discussions based on public information. Investor presentation (April 2026) reports Q4FY26 consolidated sales of Rs. 937.7 Crs (+34% Y-o-Y, +5% Q-o-Q), operating EBITDA of Rs. 321.2 Crs (+80% Y-o-Y) and operating EBITDA margin of 34.2%. FY26 consolidated sales of Rs. 3313.9 Crs (+41% Y-o-Y), operating EBITDA of Rs. 1081.7 Crs (+103% Y-o-Y), operating EBITDA margin of 32.6% and operating PBT of Rs. 814.6 Crs (+142% Y-o-Y). FY26 EPS (fully diluted) of Rs. 130.5 per share versus Rs. 58.1 in FY25 (+124%); ROE 20.1% and ROCE 21.0% in FY26 per the performance parameters slide. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 21 May 2026 | presentation Guidance, Results | Navin Fluorine International Limited has informed the Exchange about Schedule of meet and PresentationAI summaryNavin Fluorine International intimated analyst/institutional investor meetings on June 02, 2026 (Axis Capital Rising Stars Conference, physical one-on-one and group meetings), with discussions based on publicly available information. The investor presentation (April 2026) reports Q4FY26 consolidated sales of Rs. 937.7 Crs (+34% Y-o-Y, +5% Q-o-Q) and operating EBITDA of Rs. 321.2 Crs (+80% Y-o-Y), with operating EBITDA margin of 34.2%. FY26 consolidated sales were Rs. 3,313.9 Crs (+41% Y-o-Y), operating EBITDA Rs. 1,081.7 Crs (+103% Y-o-Y) and operating PBT Rs. 814.6 Crs (+142% Y-o-Y). FY26 operating EBITDA margin was 32.6% (+992 bps Y-o-Y); FY26 EPS (fully diluted) was Rs. 130.5 per share (+124%), with ROE of 20.1% and ROCE of 21.0%. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 21 May 2026 | presentation Dividend / buy-back, Results | Navin Fluorine International Limited has informed the Exchange about Schedule of meet and PresentationAI summaryNavin Fluorine International intimated that its officials will meet analysts and investors on June 08, 2026 at the ICICI Securities India Investor Conference 2026 (physical, one-on-one and group meetings), based on publicly available information. Q4FY26 consolidated sales were Rs. 937.7 Crs (+34% Y-o-Y, +5% Q-o-Q), operating EBITDA Rs. 321.2 Crs (+80% Y-o-Y) with a 34.2% margin, and operating PBT Rs. 251.0 Crs (+118% Y-o-Y). FY26 consolidated sales were Rs. 3,313.9 Crs (+41% Y-o-Y), operating EBITDA Rs. 1,081.7 Crs (+103% Y-o-Y) with a 32.6% margin, and operating PBT Rs. 814.6 Crs (+142% Y-o-Y). FY26 EPS was Rs. 130.5 per share (fully diluted), up from Rs. 54.5 in FY24 and Rs. 58.1 in FY25 (as shown in the presentation); ROE was 20.1% and ROCE 21.0% for FY26. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 21 May 2026 | presentation Results | Navin Fluorine International Limited has informed the Exchange about Schedule of meet and PresentationAI summaryNavin Fluorine International intimated analyst/institutional investor meetings on May 29, 2026 with 360 One Capital (B&K Securities) – Trinity India 2026, physical one-on-one and group meetings. Investor presentation (April 2026) shows Q4FY26 consolidated sales of Rs. 937.7 Crs (+34% Y-o-Y, +5% Q-o-Q) and operating EBITDA of Rs. 321.2 Crs (+80% Y-o-Y), with operating EBITDA margin of 34.2%. FY26 consolidated sales were Rs. 3,313.9 Crs (+41% Y-o-Y), operating EBITDA Rs. 1,081.7 Crs (+103% Y-o-Y), and operating PBT Rs. 814.6 Crs (+142% Y-o-Y). FY26 operating EBITDA margin was 32.6%, and fully diluted EPS was Rs. 130.5 per share versus Rs. 58.1 in FY25 (+124%). FY26 ROE was 20.1% and ROCE was 21.0%. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 18 May 2026 | presentation Acquisition, Results | Navin Fluorine International Limited has informed the Exchange about Schedule of meet and PresentationAI summaryNavin Fluorine International intimated an analyst/institutional investor group meeting on May 22, 2026 at 14:00 IST, with discussions based on publicly available information. Q4FY26 consolidated sales were Rs. 937.7 crore (+34% Y-o-Y, +5% Q-o-Q); operating EBITDA Rs. 321.2 crore (+80% Y-o-Y); operating EBITDA margin 34.2%. Q4FY26 operating PBT was Rs. 251.0 crore (+118% Y-o-Y). FY26 consolidated sales were Rs. 3,313.9 crore (+41% Y-o-Y); operating EBITDA Rs. 1,081.7 crore (+103% Y-o-Y); operating EBITDA margin 32.6%. FY26 operating PBT was Rs. 814.6 crore (+142% Y-o-Y); FY26 EPS (fully diluted) was Rs. 130.5 per share (+124%, versus Rs. 58.1 in FY25). Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 04 May 2026 | transcript Capex, Dividend / buy-back, Guidance, Results | Navin Fluorine International Limited has informed the Exchange about TranscriptAI summaryNavin Fluorine filed the transcript of its Q4 and FY26 earnings call held on April 29, 2026. Management said FY26 consolidated net operating revenue grew 41% to INR3,314 crores, operating EBITDA more than doubled to INR1,082 crores (margin 32.6%), and profit after tax rose to INR664 crores from INR289 crores. Management declared a final dividend of INR8.6 per equity share (430% of the face value of INR2). Management said net working capital days improved to 74 from 90, and net debt to equity stood at 0.01x as of March 31, 2026. Management said the HFC capacity of 32 MPP and the Chemours project are expected to start generating revenue in FY27, with Chemours on track for completion by end June or early July 2026. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Apr 2026 | presentation Results | Navin Fluorine International Limited has informed the Exchange about Investor PresentationAI summaryNavin Fluorine International filed its investor presentation for Q4 and FY2025-26 (quarter and year ended March 31, 2026) on April 29, 2026. Q4FY26 consolidated sales were Rs. 937.7 crore, up 34% year-on-year and 5% quarter-on-quarter; operating EBITDA was Rs. 321.2 crore (up 80% YoY), with operating EBITDA margin of 34.2%. Q4FY26 operating PBT was Rs. 251.0 crore, up 118% year-on-year. FY26 consolidated sales were Rs. 3,313.9 crore, up 41% year-on-year; operating EBITDA was Rs. 1,081.7 crore (up 103%) at a 32.6% margin. FY26 operating PBT was Rs. 814.6 crore (up 142%); FY26 EPS was Rs. 130.5 on a fully diluted basis (FY25: Rs. 58.1). Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Apr 2026 | dividend Dividend / buy-back, Management change, Results | Navin Fluorine International Limited has informed the Exchange that Board of Directors at its meeting held on April 29, 2026, recommended Final Dividend of Rs. 8.6 per equity share.AI summaryBoard meeting outcome dated April 29, 2026: audited standalone and consolidated annual results for FY ended March 31, 2026 approved. Consolidated FY2026 revenue from operations ₹3,313.90 crores (FY2025: ₹2,349.38 crores); profit after tax ₹663.56 crores (FY2025: ₹288.60 crores). Board recommended final dividend of ₹8.60 per equity share (face value ₹2), subject to AGM approval on August 06, 2026; record date June 12, 2026; payment on or after August 13, 2026. Board approved re-appointment of Vishad P. Mafatlal as Executive Chairman and KMP for 5 years from August 20, 2026, and re-appointment of independent directors Sujal A. Shah (from May 07, 2026) and Apurva S. Purohit (from October 19, 2026), subject to shareholder approval. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Apr 2026 | board outcome Dividend / buy-back, Management change, Results | Navin Fluorine International Limited has informed the Exchange regarding Outcome of Board Meeting held on April 29, 2026.AI summaryBoard of Navin Fluorine International approved audited standalone and consolidated annual results for FY ended March 31, 2026. Consolidated revenue from operations for FY2026 was ₹3,313.90 crore versus ₹2,349.38 crore in FY2025; profit after tax was ₹663.56 crore versus ₹288.60 crore. Board recommended a final dividend of ₹8.60 per equity share (face value ₹2), subject to AGM approval on August 06, 2026; record date June 12, 2026. Board approved re-appointment of Mr. Vishad P. Mafatlal as Executive Chairman and KMP for 5 years from August 20, 2026, and of Mr. Sujal A. Shah (from May 07, 2026) and Ms. Apurva S. Purohit (from October 19, 2026) as Independent Directors for 5 years, all subject to shareholder approval. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Apr 2026 | board outcome Dividend / buy-back, Management change, Results | Navin Fluorine International Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.AI summaryBoard of Navin Fluorine International approved audited standalone and consolidated annual results for FY ended March 31, 2026. Consolidated FY2026 revenue from operations was ₹3,313.90 crore and profit after tax was ₹663.56 crore, against ₹2,349.38 crore and ₹288.60 crore in FY2025. Board recommended a final dividend of ₹8.60 per equity share (430% of face value of ₹2), subject to AGM approval on August 06, 2026; record date June 12, 2026. Board approved re-appointment of Vishad P. Mafatlal as Executive Chairman and KMP for 5 years from August 20, 2026, and re-appointment of Sujal A. Shah and Apurva S. Purohit as Independent Directors for 5 years each, subject to shareholder approval. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 13 Feb 2026 | transcript Capex, Guidance, Results | Navin Fluorine International Limited has informed the Exchange about TranscriptAI summaryNavin Fluorine filed the transcript of its Q3 & nine-month FY26 earnings call held on February 9, 2026 (quarter ended December 31, 2025). Management reported nine-month FY26 revenue of INR2,376 crores (up 44% year-on-year) and Q3 FY26 revenue of INR892 crores (up 47% year-on-year); Q3 EBITDA margin was 34.5%, and Q3 profit after tax was INR185 crores. Management said the Specialty Chemicals division posted its highest-ever quarterly revenue of INR354 crores, the CDMO segment's Q3 revenue was INR127 crores, and the HPP segment's was INR412 crores. Management said the AHF project and cGMP-4 Phase-1 facility were commissioned, and that Wave-2 projects (Chemours, MPP de-bottlenecking, R32/HFC expansion) are on track for completion in FY27. Management said it now sees its annual margin at around 30%, plus or minus 200 basis points. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 10 Feb 2026 | presentation Capex, Results | Navin Fluorine International Limited has informed the Exchange about Schedule of meet and PresentationAI summaryIntimation of analyst/institutional investor meets on February 24 and 25, 2026 (Jefferies, physical, one-on-one and group meetings), with the investor presentation enclosed. Q3FY26 consolidated sales Rs. 892.4 crore, up 47% Y-o-Y and 18% Q-o-Q; operating EBITDA Rs. 307.6 crore; operating EBITDA margin 34.5%. 9MFY26 consolidated sales Rs. 2,376.2 crore, up 44% Y-o-Y; operating EBITDA Rs. 760.5 crore, up 114% Y-o-Y; operating PBT Rs. 563.6 crore, up 155% Y-o-Y. Ongoing capex includes HFC capacity expansion of up to 15,000 MTPA of R32 (Rs. 236.5 crore, commissioning by Q3FY27), MPP de-bottlenecking at Dahej (Rs. 75 crore, commissioning by Q3FY27), and Advanced Materials capacity (Rs. 120 crore, commissioning by Q1FY27). Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 10 Feb 2026 | presentation Capex, Guidance, Results | Navin Fluorine International Limited has informed the Exchange about Schedule of meet and PresentationAI summaryNavin Fluorine International intimated an analyst/institutional investor group meeting on February 18, 2026 at 13.00 IST, with discussions based on publicly available information. The filing encloses an February 2026 investor presentation covering Q3 and 9M FY26 financial performance. Q3FY26 consolidated sales were Rs. 892.4 Crs (+47% Y-o-Y, +18% Q-o-Q); operating EBITDA Rs. 307.6 Crs (+109% Y-o-Y); operating EBITDA margin 34.5%; operating PBT Rs. 243.2 Crs. 9MFY26 consolidated sales were Rs. 2376.2 Crs (+44% Y-o-Y); operating EBITDA Rs. 760.5 Crs (+114% Y-o-Y); operating EBITDA margin 32.0%; operating PBT Rs. 563.6 Crs (+155% Y-o-Y). Ongoing capex includes Rs. 236.5 Crs for additional HFC capacity of up to 15,000 MTPA of R32 (commissioning by Q3FY27), Rs. 75 Crs for MPP de-bottlenecking at Dahej (commissioning by Q3FY27), and Rs. 120 Crs for Advanced Materials capacity (commissioning by Q1FY27). Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 09 Feb 2026 | presentation Capex, Results | Navin Fluorine International Limited has informed the Exchange about Investor PresentationAI summaryNavin Fluorine International filed its Q3 FY2025-26 investor presentation (quarter ended December 31, 2025) under Regulation 30 of the SEBI LODR Regulations. Q3FY26 consolidated sales were Rs. 892.4 Crs, up 47% year-on-year and 18% quarter-on-quarter; operating EBITDA was Rs. 307.6 Crs (34.5% margin); operating PBT was Rs. 243.2 Crs. 9MFY26 consolidated sales were Rs. 2,376.2 Crs (up 44% year-on-year), operating EBITDA Rs. 760.5 Crs (32.0% margin) and operating PBT Rs. 563.6 Crs. The presentation lists ongoing capex: a HFC capacity expansion of up to 15,000 MTPA of R32 (Rs. 236.5 Crs, commissioning by Q3FY27), a Dahej MPP de-bottlenecking project (Rs. 75 Crs, commissioning by Q3FY27), and an Advanced Materials project (Rs. 120 Crs, commissioning by Q1FY27). Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 09 Feb 2026 | board outcome Dividend / buy-back, Results | Navin Fluorine International Limited has informed the Exchange regarding Board meeting held on February 09, 2026.AI summaryNavin Fluorine International's board approved unaudited standalone and consolidated results for the quarter and nine months ended December 31, 2025, on February 9, 2026. Consolidated revenue from operations for the quarter was Rs 892.37 crores, up from Rs 606.20 crores a year earlier; consolidated profit after tax was Rs 185.40 crores versus Rs 83.60 crores. Nine-month consolidated revenue from operations was Rs 2,376.19 crores and profit after tax Rs 450.94 crores. An exceptional item of Rs 20.47 crores was recognised for the impact of the New Labour Codes effective November 21, 2025. An interim dividend of Rs 6.50 per share (325%) was paid in the quarter, aggregating Rs 33.31 crores, for FY 2025-26. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 09 Feb 2026 | board outcome Dividend / buy-back, Legal, Results | Navin Fluorine International Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.AI summaryNavin Fluorine International Limited's board, at its meeting on February 9, 2026, approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. Consolidated revenue from operations for Q3 FY26 was ₹892.37 crores, up from ₹606.20 crores in the year-ago quarter; consolidated net profit (profit after tax) was ₹185.40 crores versus ₹83.60 crores a year earlier. Consolidated revenue from operations for the nine months ended December 31, 2025 was ₹2,376.19 crores, against ₹1,648.44 crores a year earlier; nine-month profit after tax was ₹450.94 crores. An exceptional item of ₹20.47 crores was recognised for the incremental employee benefit liability arising from the New Labour Codes effective November 21, 2025. An interim dividend of ₹6.50 per share (325%) was paid during the quarter, aggregating to ₹33.31 crores, for FY 2025-26. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 03 Feb 2026 | presentation | Navin Fluorine International Limited has informed the Exchange about Schedule of meet and PresentationAI summaryNavin Fluorine International Limited intimated an earnings call under Regulation 30 of the SEBI LODR Regulations. The earnings call is scheduled for Monday, February 09, 2026 at 6:30 PM IST. The call will discuss operational and financial performance for Q3 and 9M FY26 (quarter ended December 31, 2025). Participants listed in the invite include Chairman Vishad Mafatlal, Managing Director Nitin Kulkarni and CFO Anish Ganatra. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 03 Feb 2026 | presentation Capex, Guidance, Results | Navin Fluorine International Limited has informed the Exchange about Schedule of meet and PresentationAI summaryNavin Fluorine intimated analyst/institutional investor meetings on February 11, 2026 (Nuvama India Conference 2026, physical one-on-one and group meetings), with a presentation enclosed; discussions to be based on publicly available information. The enclosed investor presentation (October 2025) reports Q2FY26 consolidated sales of Rs. 758.4 Crs (+46% Y-o-Y, +5% Q-o-Q) and operating EBITDA of Rs. 246.2 Crs (operating EBITDA margin 32.5%). Q2FY26 operating PBT was Rs. 179.3 Crs (+173% Y-o-Y); H1FY26 sales were Rs. 1483.8 Crs (+42% Y-o-Y) and H1FY26 operating EBITDA Rs. 453.0 Crs (+118% Y-o-Y). The presentation discloses HFC capacity capex of up to 15,000 MTPA of R32 (Rs. 236.5 Crs, commissioning by Q3 FY27) and Dahej MPP de-bottlenecking capex of Rs. 75 Crs (commissioning by Q3 FY27), both funded by internal accruals. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 17 Nov 2025 | presentation Capex, Guidance, Results | Navin Fluorine International Limited has informed the Exchange about Schedule of meet and PresentationAI summaryNavin Fluorine intimated analyst/institutional investor meets on November 21, 2025 (JM Financial conference, physical one-on-one and group meetings), with an investor presentation dated October 2025 enclosed. Q2FY26 consolidated sales were Rs. 758.4 crores, up 46% Y-o-Y and 5% Q-o-Q; operating EBITDA was Rs. 246.2 crores (up 129% Y-o-Y); operating EBITDA margin was 32.5%. Q2FY26 operating PBT was Rs. 179.3 crores, up 173% Y-o-Y. H1FY26 consolidated sales were Rs. 1483.8 crores (up 42% Y-o-Y); H1FY26 operating EBITDA was Rs. 453.0 crores (up 118% Y-o-Y), with margin of 30.5%. Capex announced: additional HFC capacity equivalent to up to 15,000 MTPA of R32 at Rs. 236.5 crores, expected to be commissioned by Q3 FY27; and Dahej MPP de-bottlenecking at Rs. 75 crores, targeted for commissioning by Q3 FY27. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 14 Nov 2025 | presentation Capex, Results | Navin Fluorine International Limited has informed the Exchange about Schedule of meet and PresentationAI summaryNavin Fluorine International intimated an analyst/institutional investor meet on November 19, 2025, with an investor presentation (October 2025) enclosed. Q2FY26 consolidated sales were Rs. 758.4 crore, up 46% Y-o-Y and 5% Q-o-Q; operating EBITDA was Rs. 246.2 crore (up 129% Y-o-Y); operating EBITDA margin was 32.5%; operating PBT was Rs. 179.3 crore. H1FY26 consolidated sales were Rs. 1483.8 crore, up 42% Y-o-Y; operating EBITDA was Rs. 453.0 crore (up 118% Y-o-Y); operating EBITDA margin was 30.5%; operating PBT was Rs. 320.5 crore (up 159% Y-o-Y). Capex announced: additional HFC capacity of up to 15,000 MTPA of R32 at Rs. 236.5 crore, expected to be commissioned by Q3 FY27; and Dahej MPP debottlenecking at Rs. 75 crore, targeted for commissioning by Q3 FY27. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 12 Nov 2025 | presentation Capex, Results | Navin Fluorine International Limited has informed the Exchange about Schedule of meet and PresentationAI summaryNavin Fluorine International intimated analyst/institutional investor meetings on November 17, 2025 (Avendus Spark INDX Annual Investor Conference, physical one-on-one and group meetings), with an October 2025 investor presentation attached. Q2FY26 consolidated sales Rs. 758.4 crores, up 46% Y-o-Y and 5% Q-o-Q; operating EBITDA Rs. 246.2 crores (up 129% Y-o-Y); operating EBITDA margin 32.5%; operating PBT Rs. 179.3 crores. H1FY26 consolidated sales Rs. 1483.8 crores, up 42% Y-o-Y; operating EBITDA Rs. 453.0 crores; operating EBITDA margin 30.5%; operating PBT Rs. 320.5 crores. Capex announced: additional HFC capacity equivalent to up to 15,000 MTPA of R32 at Rs. 236.5 crores, targeted for commissioning by Q3 FY27; and MPP de-bottlenecking at Dahej at Rs. 75 crores, targeted for commissioning by Q3 FY27. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 11 Nov 2025 | credit rating Rating | Navin Fluorine International Limited has informed the Exchange about Credit Rating- NewAI summaryNavin Fluorine International Limited disclosed under Regulation 30 of SEBI Listing Regulations that ESG Risk Assessments & Insights Limited assigned it an ESG Rating of "61" by email received on November 11, 2025. The company is in the 'Strong' ESG rating category. The company states it did not engage ESG Risk Assessments & Insights Limited for the rating; the report was independently prepared using public domain data. The intimation is also available on the company's website, www.nfil.in. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 04 Nov 2025 | transcript Capex, Dividend / buy-back, Guidance, Results | Navin Fluorine International Limited has informed the Exchange about TranscriptAI summaryNavin Fluorine filed the transcript of its Q2 and H1 FY26 earnings call held on October 30, 2025. Management said Q2 revenue rose 46% year-on-year to INR758 crores, with operating EBITDA of INR246 crores (32.5% margin) and PAT of INR148 crores; H1 revenue rose 42% to INR1,484 crores with PAT of INR266 crores. The Board declared an interim dividend of INR6.5 per share (face value INR2) and approved two capex projects: INR236.5 crores for up to 15,000 tonnes per annum of R32 capacity and INR75 crores for MPP debottlenecking at Dahej. Management expects FY26 EBITDA margin between 28% and 30%, with FY26 cash-outflow capex of about INR600-700 crores and a frame of about INR1,000 crores over the next couple of years. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
The list of announcements the National Stock Exchange publishes for the company; each link opens the exchange's own copy. Ask Sensei searches these filings when a question names the company.